Amgen

AMGN · NASDAQ · USD

$411.26−2.43%−$10.25

Close · October 1, 2026

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total revenue	36,751	33,424	28,190	26,323	25,979	25,424	23,362	23,747	22,849	22,991
Cost of revenue	10,737	10,458	7,795	6,376	6,454	6,159	4,356	4,101	4,069	4,162
Gross profit	26,014	22,966	20,395	19,947	19,525	19,265	19,006	19,646	18,780	18,829
Selling, general and administrative	7,050	7,096	5,692	5,414	5,368	5,730	5,150	5,332	4,870	5,120
Research and development	7,272	5,964	4,784	4,434	4,819	4,207	4,116	3,737	3,562	3,840
Operating income	11,574	9,676	9,823	10,098	9,151	9,328	9,740	10,551	10,340	9,832
EBIT	11,574	9,676	9,823	10,098	9,151	9,328	9,740	10,551	10,340	9,832
EBITDA	16,617	15,157	13,755	13,358	12,549	12,929	11,775	12,481	12,244	11,937
Interest expense	3,163	3,665	4,100	1,533	1,208	998	1,289	1,392	1,303	1,259
Pre-tax income	8,976	4,609	7,855	7,346	6,701	8,133	9,138	9,545	9,597	9,163
Income tax	1,265	519	1,138	794	808	869	1,296	1,151	7,618	1,441
Net income	7,711	4,090	6,717	6,552	5,893	7,264	7,842	8,394	1,979	7,722
Net income to common shareholders	7,711	4,090	6,717	6,552	5,893	7,264	7,842	8,394	1,979	7,722
Basic EPS	14.33	7.62	12.56	12.18	10.34	12.40	12.96	12.70	2.71	10.32
Diluted EPS	14.23	7.56	12.49	12.11	10.28	12.31	12.88	12.62	2.69	10.24
Average shares (basic)	538	537	535	538	570	586	605	661	731	748
Average shares (diluted)	542	541	538	541	573	590	609	665	735	754
Dividend per share	9.52	9.00	8.52	7.76	7.04	6.40	5.80	5.28	4.60	4.00